false
Catalog
Transforming AF Treatment: Innovations to the FARA ...
Transforming AF Treatment: Innovations to the FARA ...
Transforming AF Treatment: Innovations to the FARAPULSE Portfolio
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video discusses advancements in atrial fibrillation (AFib) treatment, focusing on the development and application of the FirePulse system and other new technologies. Dr. Amin Al-Ahmad, accompanied by other experts, discusses the FirePulse system's global adoption and its impact on AFib management. The system has been used to treat over 200,000 patients worldwide. The discussion highlights the efficiency of the system, particularly its ability to perform single-catheter workflows and deliver lesions during mapping, resulting in more efficient ablations. The FireWave system's components, such as the pentaspline catheter, integrated mapping systems, and the new Faraflex catheter, are explored.<br /><br />The Faraflex, a recent addition not yet approved in the US, shows promise in mapping and ablation, particularly for persistent AFib. Additionally, advancements in electrographic flow-guided ablation using the Optimap catheter are discussed, which may help in identifying patient-specific ablation targets. The panel also touches on the Disrupt AF registry, which aims to collect real-world data on the FirePulse's impact on procedural practice and patient outcomes. Overall, the session underscores the transformative potential of these technologies in addressing the complexities of AFib treatment.
Keywords
Atrial Fibrillation
FirePulse system
AFib management
single-catheter workflows
Faraflex catheter
electrographic flow-guided ablation
Disrupt AF registry
pentaspline catheter
Optimap catheter
Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy
|
Cookie Declaration
|
Linking Policy
|
Patient Education Disclaimer
|
State Nonprofit Disclosures
|
FAQ
×
Please select your language
1
English